Tobeka Boltina qualified as a medical doctor in 1993, and further completed a Diploma in Occupational Health and a Graduate Certificate in Pharmaco-Economics.
Prior to joining the pharmaceutical industry in 2002, she had assumed clinical duties in her capacity as General Practitioner, Medical Officer and Occupational Health Practitioner.
Her career in the pharmaceutical industry commenced in 2002, and she has worked in different roles as a Medical Advisor, Head of Public Affairs and Communications, Regional Medical Monitor for Clinical Trials, and Medical Director.
During the years 2013 to 2015, Tobeka was a Technical Lead for the Health Products Task Team that established the South African Health Regulatory Authority (SAHPRA) that replaced the Medicines Control Council, and also Technical Lead for the Office of Health Standards Compliance (OHSC).
Tobeka is currently Head: Clinical, Medical & Regulatory Affairs at Novo Nordisk, where her role spans across clinical research, life cycle management of products, ensuring launch readiness, conducting scientific engagement and stakeholder management, managing a patient support programme; all with the objective of improving access to Novo Nordisk therapies, and enhancing outcomes for patients.
In 2008, Tobeka Boltina was nominated to be a member of the Swiss South African Co-operation Initiative (SSACI) Board of Trustees. She was re-nominated in 2009, 2010, 2011 and held the position until November 2012.